Cytokine responses to the anti-schistosome vaccine candidate antigen glutathione-S-transferase vary with host age and are boosted by praziquantel treatment.

<h4>Background</h4>Improved helminth control is required to alleviate the global burden of schistosomiasis and schistosome-associated pathologies. Current control efforts rely on the anti-helminthic drug praziquantel (PZQ), which enhances immune responses to crude schistosome antigens bu...

Full description

Saved in:
Bibliographic Details
Main Authors: Claire D Bourke, Norman Nausch, Nadine Rujeni, Laura J Appleby, François Trottein, Nicholas Midzi, Takafira Mduluza, Francisca Mutapi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0002846
Tags: Add Tag
No Tags, Be the first to tag this record!